Real-time enrollment status for this pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: September 4, 2026 at 12:20 PM UTC
| NCT Number | NCT07226154 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | August 19, 2026 (2 weeks ago) |
As of September 4, 2026: Clinical trial NCT07226154 is currently recruiting participants. This clinical trial study for pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07226154 is actively recruiting participants as of September 4, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07226154 was last updated 2 weeks ago (August 19, 2026). HelloStudys verifies this status automatically.